EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 31 January 2019

Real-world outcomes: cancer data partnership puts patients first

A special mention from the Health Collaboration Awards jury

NHS Wales Haematological Malignancy Data Solution received a special mention from the Health Collaboration Awards jury for their highly innovative approach of using data to optimise treatments.

A radical new data solution is set to capture myeloma patient experience, paving the way for personalised care and ‘commissioning for outcomes’.

NHS Wales is fast-becoming a leader in value-based healthcare. The latest example of its willingness to experiment with new models can be seen in a bold collaboration designed to rethink cancer care. Read more

Blogs

Can GDPR work for health scientific research?
31 January 2019 - Brendan Barnes

As the workshop report commented “the health research sector has so far survived GDPR rather than being strengthened... Read more

A positive agenda for intellectual property in Switzerland
29 January 2019

While the European Union seems to be backtracking on its commitment to strong IP framework, its competitors go in the... Read more

Videos

Interview with Nathalie Moll, Director General, EFPIA
ITN presenter Natasha Kaplinsky is joined by Nathalie Moll, EFPIA Director General, to talk about the commitment of... Read more

For The Chance
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the... Read more

Events

Antimicrobial Resistance Summit
26 March 2019 (BMA, London)

Dame Sally Davies, chief medical officer, UK Government, among other speakers, will be joining the discussion. 20% discount... Read more

EFGCP Annual Conference 2019: Making Clinical Research an Element of Better Healthcare
19 February 2019 (University Foundation, Brussels, Belgium)

What are the current challenges & immediate needs of clinical research? How to ensure patient centricity in treatment... Read more

What we are reading

SPC stockpiling provision would further damage European innovation
On 29 January 2019 (Geneva Network)

Philip Stevens, Director, Geneva Network: The introduction of the SPC manufacturing export... Read more

Pharma industry raises the alarm about stockpiling of generic drugs
On 29 January 2019 (Euractiv)

The industry of innovative medicines is concerned about a recent vote in the European... Read more

Brexit: What preparations are being made for a no-deal?
On 31 January 2019 (BBC)

It could become the UK's biggest peacetime emergency in almost a century. Unless a withdrawal... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu